The Blog
-
May 20, 2025Tyrosine Kinases in Cancer: From Molecular Mechanisms to Targeted Therapies
READ MORE -
May 16, 2025KRAS-Targeted Drugs: From Discovery to Clinical Application
READ MORE -
Apr 29, 2025Inavolisib: A Breakthrough in Cancer Treatment and PI3K Inhibitio
READ MORE -
Mar 27, 2025Vorasidenib and Low-Grade Gliomas: A Promising New Therapy with Open Questions
READ MORE -
Feb 14, 2025Targeting DLL3 in Small Cell Lung Cancer: New Hope for Treatment Breakthroughs
READ MORE -
Jan 23, 2025Inavolisib: A New Hope in Targeted Therapy for HR+ HER2-Negative Breast Cancer
READ MORE -
Jan 22, 2025Everything You Need to Know About Ensartinib for ALK-Positive Non-Small Cell Lung Cancer
READ MORE -
Jan 21, 2025Tovorafenib: A Breakthrough in Treating Pediatric Low-Grade Gliomas
READ MORE -
Dec 03, 2024How ABT-199 (Venetoclax) is Changing the Treatment Landscape for Blood Cancers
READ MORE